Cigna, HCSC and Novo have taken part in a $50m funding round for MDLive, a telehealth platform already backed by Sentara and Sutter Health.
US-based telehealth platform operator MDLive has closed a $50m funding round co-led by insurance providers Cigna and Health Care Service Corporation (HCSC) together with venture capital firm Health Velocity Capital.
Pharmaceutical group Novo Holdings and investment firm Industry Ventures also participated, and Tiba Aynechi, partner at Novo subsidiary Novo Ventures, has joined MDLive’s board of directors in conjunction with the round.
MDLive operates a cloud-based health services platform that offers round-the-clock consultations for medical, dermatological and behavioural conditions from certified…
